Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin-Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01359592
What this trial is testing

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 159
Testing effectiveness (Phase 2)UnknownNCT05631912
What this trial is testing

TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Chinese PLA General Hospital 38
Large-scale testing (Phase 3)Study completedNCT01144364
What this trial is testing

MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 234
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313852
What this trial is testing

Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-Cell Acute Lymphoblastic Leukemia, AdultB-ALL
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT03200015
What this trial is testing

Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Hospital Universitario Dr. Jose E. Gonzalez 15
Early research (Phase 1)Study completedNCT00003289
What this trial is testing

UCN-01 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT01606878
What this trial is testing

Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Who this might be right for
Childhood Solid NeoplasmRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Neuroblastoma
Children's Oncology Group 46
Very early researchEnded earlyNCT01878708
What this trial is testing

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
T-Cell LymphomaRelapsed T-Cell LymphomaRefractory T-Cell Lymphoma
Dana-Farber Cancer Institute 2
Not applicableStudy completedNCT06610617
What this trial is testing

Neuromodulation of Central Sensory Integration to Improve Postural Control

Who this might be right for
SurvivorshipQuality of LifeCognitive Deficits, Mild
University of Pittsburgh 48
Testing effectiveness (Phase 2)Looking for participantsNCT06530550
What this trial is testing

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 51
Testing effectiveness (Phase 2)Study completedNCT02362035
What this trial is testing

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Who this might be right for
Follicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more
Acerta Pharma BV 161
Testing effectiveness (Phase 2)Looking for participantsNCT04792489
What this trial is testing

DALY II USA/ MB-CART2019.1 for DLBCL

Who this might be right for
Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell LymphomaHigh Grade B-cell Lymphoma (HGBCL)+6 more
Miltenyi Biomedicine GmbH 315
Not applicableStudy completedNCT01266668
What this trial is testing

The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Chonbuk National University Hospital 100
Not applicableStudy completedNCT04858568
What this trial is testing

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Who this might be right for
Classical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more
University Hospital Southampton NHS Foundation Trust 592
Not applicableUnknownNCT04237168
What this trial is testing

Non-invasive Tumor Immunoglobulin Gene Next Generation Sequencing (IgNGS) in Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Testing effectiveness (Phase 2)UnknownNCT02878278
What this trial is testing

Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation

Who this might be right for
Lymphoma, Extranodal NK-T-CellEBV
Huiqiang Huang 24
Not applicableEnded earlyNCT00594308
What this trial is testing

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Indiana University 10
Not applicableApproved For MarketingNCT05733650
What this trial is testing

Expanded Access Program for Epcoritamab

Who this might be right for
Large B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+2 more
Genmab
Testing effectiveness (Phase 2)UnknownNCT02267915
What this trial is testing

Phase II of Efficacy and Toxicity of Maintenance Sub. Rituximab After Induction in Relapsed MCL and Non-eligible HSCT

Who this might be right for
Mantle-cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 36
Testing effectiveness (Phase 2)Study completedNCT00002635
What this trial is testing

Aminocamptothecin in Treating Patients With T-cell Lymphoma

Who this might be right for
Lymphoma
Yale University 12
Next Page